Registrant : Organisation or self-employed individual
Sections
| Section: |
II - In-house lobbyists and trade/professional associations |
| and more precisely: |
Companies & groups |
Person with legal responsibility
| Surname, Name: |
Mr
Ian C. Read
|
| Position: |
CEO |
Permanent person in charge of EU relations
| Surname, Name: |
Mrs
Eva Grut-Aandahl
|
| Position: |
Head of EU Office |
Contact details:
| Contact details of organisation's head office: |
235 East 42nd Street
New York NY 10017
UNITED STATES
|
| Telephone number: |
(+1) 2127332323 |
| Fax number: |
(+) |
| Other contact information: |
Contact details of Brussels office:
Pfizer European Public Affairs and Policy,
Boulevard de la Plaine/Pleinlaan 17,
B-1050 Brussels
Tel: +32 2 554 62 11
Fax: +32 2 554 66 60
|
Goals / remit
| Goals / remit of the organisation: |
Pfizer is a research-based biomedical and pharmaceutical company, headquartered in New York. Our mission is to apply innovative science to improve world health through the invention of new medicines. In 2011, Pfizer's revenue was 67.4bn, with approx. 6bn invested in research and development.
|
|
The organisation's fields of interests are:
|
|
Number of persons engaged in activities falling under the scope of the Transparency Register
| Number of persons: |
22
|
|
Complementary information:
|
Some are full-time engaged in the Brussels office (6) and will spend approx 50% of time with EU affairs, whereas others may only spend a fraction of their time (between 1.5%-10%)
|
Persons accredited for access to European Parliament premises
| First name
|
Surname
|
Start Date |
End Date |
|
Matthew Thomas
|
CLAY
|
17/01/13
|
05/12/13
|
|
EVA GRUT
|
AANDAHL
|
14/02/13
|
12/02/14
|
Activities
Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:
|
Pharmaceuticals, healthcare, innovation and research, intellectual property, business competitiveness, trade, environment
|
Fields of interest for e-mail alerts on consultations and roadmaps;
| Fields declared by the organisation: |
- Competition
- Consumer Affairs
- Customs
- Economic and Financial Affairs
- Enlargement
- Enterprise
- Environment
- External Relations
- General and Institutional Affairs
- Internal Market
- Justice and Fundamental Rights
- Public Health
- Research and Technology
- Trade
|
Networking
Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.
|
Pfizer is a member of: EFPIA, EBE, EVM, EuropaBio, AESGP, IFAH-Europe, Amcham EU, Britcham, BusinessEurope, TPN, TABD
|
Financial data
| Financial year: |
01/2011
-
12/2011
|
|
Estimated costs to the organisation directly related to representing interests to EU institutions in that year:
|
500000
€ - 600000
€
|
|
Amount and source of funding received from the EU institutions in financial year n-1 of registration
|
|
Procurement:
|
0 €
|
|
Grants:
|
0 €
|
Other (financial) information provided by the organisation:
|
This estimate is based on the pro rata salary costs of Pfizer staff involved in interest representation to the European institutions, based on the proportion of employee time spent on these activities. A proportion of overheads for our Brussels office is included in the estimate on the same basis. Membership fees and payments to third parties are not included to avoid double counting.
|
|
